1. Home
  2. DYAI vs PYN Comparison

DYAI vs PYN Comparison

Compare DYAI & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • PYN
  • Stock Information
  • Founded
  • DYAI 1979
  • PYN 2002
  • Country
  • DYAI United States
  • PYN United States
  • Employees
  • DYAI N/A
  • PYN N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • PYN Investment Managers
  • Sector
  • DYAI Health Care
  • PYN Finance
  • Exchange
  • DYAI Nasdaq
  • PYN Nasdaq
  • Market Cap
  • DYAI 28.3M
  • PYN 30.1M
  • IPO Year
  • DYAI 2004
  • PYN N/A
  • Fundamental
  • Price
  • DYAI $1.13
  • PYN $5.09
  • Analyst Decision
  • DYAI Strong Buy
  • PYN
  • Analyst Count
  • DYAI 1
  • PYN 0
  • Target Price
  • DYAI $6.00
  • PYN N/A
  • AVG Volume (30 Days)
  • DYAI 203.9K
  • PYN 19.9K
  • Earning Date
  • DYAI 08-12-2025
  • PYN 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • PYN 5.07%
  • EPS Growth
  • DYAI N/A
  • PYN N/A
  • EPS
  • DYAI N/A
  • PYN N/A
  • Revenue
  • DYAI $3,554,344.00
  • PYN N/A
  • Revenue This Year
  • DYAI $22.56
  • PYN N/A
  • Revenue Next Year
  • DYAI $30.95
  • PYN N/A
  • P/E Ratio
  • DYAI N/A
  • PYN N/A
  • Revenue Growth
  • DYAI 57.59
  • PYN N/A
  • 52 Week Low
  • DYAI $0.91
  • PYN $4.84
  • 52 Week High
  • DYAI $2.20
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 62.78
  • PYN 35.88
  • Support Level
  • DYAI $1.08
  • PYN $5.05
  • Resistance Level
  • DYAI $1.20
  • PYN $5.12
  • Average True Range (ATR)
  • DYAI 0.08
  • PYN 0.06
  • MACD
  • DYAI 0.02
  • PYN -0.01
  • Stochastic Oscillator
  • DYAI 50.00
  • PYN 14.81

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: